Abstract:Osteoporosis is a major concern worldwide and can be attributed to an imbalance between osteoblastic bone formation and osteoclastic bone resorption due to the natural aging process. Heritable factors account for 60–80% of optimal bone mineralization; however, the finer details of pathogenesis remain to be elucidated. Micro RNA (miRNA) and long-non-coding RNA (lncRNA) are two targets that have recently come into the spotlight due to their ability to control gene expression at the post-transcriptional level and provide epigenetic modification. miRNAs are a class of non-coding RNAs that are approximately 18–25 nucleotides long. It is thought that up to 60% of human protein-coding genes may be regulated by miRNAs. They have been found to regulate gene expression that controls osteoblast-dependent bone formation and osteoclast-related bone remodeling. lncRNAs are highly structured RNA transcripts longer than 200 nucleotides that do not translate into proteins. They have very complex secondary and tertiary structures and the same degradation processes as messenger RNAs. The fact that they have a rapid turnover is due to their sponge function in binding the miRNAs that lead to a degradation of the lncRNA itself. They can act as signaling, decoy, and framework molecules, or as primers. Current evidence suggests that lncRNAs can act as chromatin and transcriptional as well as post-transcriptional regulators. With regards to osteoporosis, lncRNA is thought to be involved in the proliferation, apoptosis, and inflammatory response of the bone. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on the roles of miRNAs and lncRNAs in osteoporosis. Further research into the epigenetic modification and the regulatory roles of these molecules will bring us closer to potential disease-modifying treatment for osteoporosis. However, more issues regarding the detailed actions of miRNAs and lncRNAs in osteoporosis remain unknown and controversial and warrant future investigation.

Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential

The regulatory roles of long noncoding RNAs in osteoporosis

Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis

A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis

Lncrnas: Function and Mechanism in Cartilage Development, Degeneration, and Regeneration

The Multiple Function of Long Noncoding RNAs in Osteosarcoma Progression, Drug Resistance and Prognosis.

CircRNAs and LncRNAs in Osteoporosis

Research and Application of Target Therapy for Osteoporosis

Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects

Network regulatory mechanism of ncRNA on the Wnt signaling pathway in osteoporosis

Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis

The roles of miRNA, lncRNA and circRNA in the development of osteoporosis

Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review)

LncRNA, Important Players in Bone Development and Disease.

Role of long non-coding RNA H19 in the development of osteoporosis

Noncoding RNAs: the crucial role of programmed cell death in osteoporosis

Application of Exosome-Derived Noncoding RNAs in Bone Regeneration: Opportunities and Challenges

A novel long noncoding RNA AK016739 inhibits osteoblast differentiation and bone formation

The emerging role of lncRNAs in osteoarthritis development and potential therapy

LncRNA, Important Player in Bone Development and Disease